🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

HALO HALO

Company Profile ↓
$83.59
+39.34% 1Y
P/E32.65
52W High$83.59
52W Low$59.99
EPS (TTM)$2.56

Company Overview

HALO (HALO) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 20.0%.

Consistent Profit Growth

Net profit has compounded at 19.7% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 33.5% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 22.7%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $1.40B (+37.6% YoY); net profit $316.89M.
  • Trailing 12 Months Year-on-year growth — revenue +37.5%, earnings -28.6%.
  • 5-Year Trend Long-term compounding — revenue CAGR 33.5%, profit CAGR 19.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:33.53%
1 Year:37.55%

Compounded Profit Growth

5 Years:19.68%
1 Year:-28.64%

Stock Price Performance

1 Year:+39.34%
6 Months:+9.30%
3 Months:+26.90%
1 Month:+2.48%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 100% of range
$59.99 $83.59
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)66.96 · Neutral
Price Performance
1M+2.48%
3M+26.90%
6M+9.30%
1Y+39.34%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Excellent profit margin of 22.7%.
  • Compounding revenue at 33.5% over 5 years.
  • Profit CAGR of 19.7% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
32.65
Industry PE
-
Forward P/E est.
45.75
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
33.53%
Profit 5Y
19.68%
Revenue (YoY)
37.55%
Earnings (YoY)
-28.64%

Profitability & Returns

ROCE
19.97%
ROE
-
ROA
12.55%
Profit Margin
22.69%
Op Margin
33.58%
Gross Margin
-
EPS (Latest Qtr)
$1.22
EPS (TTM)
$2.56

Balance Sheet & Liquidity

Debt/Equity
9.76
Quick Ratio
2.33
Current Ratio
2.76
Debt
$2.14B
Total Assets
$2.67B
Current Assets
$1.00B
Working Capital
$639.83M

Ownership

Promoter Holding
1.06%
Chg in Prom Hold
-
FII / Inst Holding
108.41%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$1.40B
EBITDA
-
Free Cash Flow
$644.59M
Operating Cash Flow
$651.56M
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ------------30.87M35.20M25.56M-56.95M39.15M46.23M-25.35M55.22M65.32M-89.02M136.46M115.83M117.28M152.37M208.98M162.14M221.04M216.03M195.88M231.35M290.08M264.86M325.72M354.26M376.71M
Gross Profit 5.18M5.39M4.20M5.42M5.18M5.39M4.20M5.42M3.89M4.99M5.26M5.11M3.75M3.65M5.64M5.06M3.74M3.88M6.87M6.01M2.36M597.00K3.48M6.18M----------------
Operating Income -13.91M4.23M-23.24M--16.17M-21.72M-22.74M--27.53M-25.48M8.08M--23.71M-20.07M-25.47M-2.97M-13.98M-24.54M--3.22M29.55M40.30M-50.73M93.05M75.59M75.67M34.06M83.29M53.80M94.46M88.28M95.54M117.23M163.20M141.53M202.44M217.92M184.52M
Net Income -19.82M-26.88M-28.95M-27.39M-19.82M-26.88M-28.95M-27.39M-32.90M-30.76M2.75M123.88M-27.46M-22.89M-27.85M-2.13M1.80M-14.62M-25.02M-34.40M-6.10M25.82M36.21M73.16M27.89M91.46M216.59M60.11M22.68M61.63M39.62M74.75M81.84M76.82M93.25M137.01M118.09M165.16M175.22M150.05M
Diluted EPS -0.120.02-0.190.03-0.120.02-0.230.03-260.00-230.0020.00850.00-0.19-0.16-0.19-0.010.01-0.10-0.17-0.24-0.040.190.250.500.190.621.480.430.160.440.290.560.610.600.721.050.931.331.431.22
R&D Expense 16.68M21.20M27.61M-40.10M35.53M33.86M-36.94M38.34M33.99M-37.98M40.09M35.54M-31.33M33.91M30.45M-10.16M8.95M7.75M-9.01M8.07M8.49M11.85M15.48M16.70M17.98M19.73M17.32M19.11M21.04M18.46M14.80M17.54M17.25M25.56M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 13.67M13.62M56.09M42.33M54.80M75.33M135.06M146.69M316.61M151.86M195.99M267.59M443.31M660.12M829.25M1.02B1.40B
Operating Income -58.46M-54.26M-19.84M-53.62M-80.43M-63.04M-27.45M-83.21M81.00M-69.33M-67.61M144.25M275.90M267.53M337.57M551.48M469.01M
Net Income -58.36M-53.24M-19.77M-53.55M-83.48M-68.38M-32.23M-103.02M62.97M-80.33M-72.24M129.09M402.71M202.13M281.59M444.09M316.89M
Diluted EPS -------0.25-0.810.45-0.56-0.500.912.741.442.103.432.56
R&D Expense 56.61M51.77M57.56M70.04M96.64M79.70M93.24M150.84M150.64M150.25M140.80M34.24M35.67M66.61M76.36M79.05M-

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --91.35M65.76M134.73M101.79M165.98M181.79M261.51M519.95M440.25M565.87M579.92M1.10B1.84B1.73B2.06B2.53B
Total Equity 15.38M6.90M20.35M10.90M48.85M-19.99M41.35M43.00M-32.48M208.37M248.89M91.77M151.05M196.95M169.80M83.81M363.82M48.81M
Cash & Equivalents 63.72M67.46M82.76M52.38M99.50M27.36M61.39M43.29M66.76M168.74M57.94M120.18M147.70M118.72M234.19M118.37M115.85M133.82M
Long Term Debt ---029.66M49.77M49.86M27.97M199.23M125.14M34.87M383.05M0787.25M1.49B1.50B1.51B2.14B
Total Liabilities --------------1.67B1.65B1.70B2.48B
Current Liabilities --15.34M17.30M18.95M24.90M24.33M62.46M54.59M131.33M149.36M85.64M421.38M117.15M130.79M112.49M139.10M177.09M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -40.15M-45.39M-34.30M-64.28M-49.34M-47.52M-37.08M-50.38M134.05M-49.50M-85.42M55.45M299.44M240.11M388.57M479.06M651.56M
Investing Cash Flow -1.46M-646.54K-828.51K-1.41M-47.87M-32.95M5.89M-76.77M-163.73M2.49M-5.55M78.35M-406.29M-487.00M-96.91M-262.72M-545.81M
Financing Cash Flow 45.36M61.82M4.75M112.82M25.06M114.50M13.10M150.62M131.66M-63.80M153.22M-106.28M77.86M362.37M-407.99M-218.86M-85.17M
Capital Expenditure -1.46M-646.54K-828.51K-1.41M-2.30M-1.37M-2.36M-3.14M-1.35M-4.66M-4.04M-2.50M-1.46M-4.81M-15.29M-10.70M-6.97M
Free Cash Flow -41.61M-46.03M-35.13M-65.69M-51.64M-48.89M-39.44M-53.52M132.70M-54.16M-89.46M52.95M297.98M235.30M373.28M468.37M644.59M
Share Buybacks --------00200.00M150.12M350.06M200.00M402.38M250.00M342.37M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------------
Operating Margin % -427.6%-398.2%-35.4%-126.7%-146.8%-83.7%-20.3%-56.7%25.6%-45.7%-34.5%53.9%62.2%40.5%40.7%54.3%33.6%
Net Margin % -426.9%-390.8%-35.2%-126.5%-152.3%-90.8%-23.9%-70.2%19.9%-52.9%-36.9%48.2%90.8%30.6%34.0%43.7%22.7%
ROE % -845.4%-261.6%-181.4%-109.6%417.6%-165.3%-75.0%317.2%30.2%-32.3%-78.7%85.5%204.5%119.0%336.0%122.1%649.2%
ROCE % --71.4%-40.9%-46.3%-104.6%-44.5%-23.0%-40.2%20.8%-23.8%-14.1%91.0%27.9%15.6%20.8%28.7%20.0%

Shareholding Pattern

Insiders
1.06%
Institutions
108.41%
Public Float
109.58%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HALO

Google News Wed, 03 Jun 2026

Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVXJHNEl4ckN3QUtSR3pUdUNvbXo4VmZkUnd6Y2Vza0FVZGp6RUtPQVZFbUhkX192SzFFNkN4QTZCNmVlVjlzYTVMdFJNZTVhT3ltRktGRVVZNjlZdmFINDlMTUVlQUk2cmFsMm52OTVEMVR3NnVrUDIwbldwbmtJMXFPbVNibmRxdUxJd0…

Google News Sat, 01 Aug 2026

HALOZYME THERAPEUTICS INC (HALO) Stock Chart - ChartMill

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE9tZDRCM0M5S09UcUgxRHRtWS1ZLTE0WTU2S1hwU01hZ0VCNFZLUVRsdE5jaU85ckZsZGgyVTZ5QXFEalJTdUNLbEQ1MmlMQ3NfUW1KNXhzenlma1d0c19lZTJXVjM?oc=5" target="_blank">HALOZYME THERAPEUTICS INC (HALO)…

Google News Mon, 03 Aug 2026

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Evaluating the Growth Potential Amid Robust Revenue Expansion - DirectorsTalk Interviews

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxQdE0wN1c4cjhQNEJxTzNMOHlWODVsMU9IM1dXbXk0R093RHVOR2UyY2lRRnhNdklxb0pXS0RLTThkTW5HUmtMUktYUU1vM1g0azFaZnBBd3hsb0tEUXJrS21TY05lcHRqVVFOTy0tSDZ1bmxkRm1sN3RSRENZbnZPZGszdGczd1VmdXB6dE…

Google News ue, 04 Aug 2026

What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings - StockStory

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQWkpHTGxGRm5ndHJkR3VCUlNEUlFlSHl5Mk1Nb004LWUxT3FOZjFLZ1NaOGZuSkduM1VJU0FMZGdxSldiX3BGV1RoVWdObFJnUGZxdy1SU0VIN1U1TWdDcDJqZUkyc192akxMYmtnenJNZ0VhdVNNYmZVZkk0cVkyQUN2RnowNzJPUDFJUT…

Google News Fri, 26 Jun 2026

HALO Stocks in Emerging Markets Could Extend Rally as Heavy Industries Surge - Goldman Sachs

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNZXkxN3RtMENDVjUzaFBhSWc0LTk5MzJHZVBEVXNnVnlLajdkSlNsUlZUdGhpVTlYTWlkMUpvMWhBcjZ4Wk52dHNyUFl5N0xmWDV4aEw0cU83QXo3YVpWZFR4b1JBSUtBNmEteGJwSFlYZlpmUmE4eEowT2RxWUFOaVZYOWFELWhObWE5MW…

Google News ue, 04 Aug 2026

What Is the HALO Trade? Earnings, Not Assets, Will Decide the Next Winners - EBC Financial Group

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE5yalRTVFVyeUN6SDM2cWFVNldJNFVnTFNyQVdHRE1YZXJ1RFRHZmZJZjE4XzdCYU5ERUYzUmVxTmRHaThSVzVTcGFwY0JMYUdoR05qVzZGWmN4YWRjSE1va1g4eV9EMHBVRDVweVJUZWRhRy1l?oc=5" target="_blank">What Is the…

HALO — Frequently Asked Questions

What is the current share price of HALO?

As of 2026-08-05 17:25 PDT, HALO trades at $83.59 on NASDAQ/NYSE. Its 52-week range is $59.99 to $83.59.

What is the P/E ratio of HALO?

HALO trades at a trailing price-to-earnings (P/E) ratio of 32.65.

Is HALO a good stock to buy?

This page provides a data-driven analysis of HALO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space